A Phase 1/2 Study of HS-410 in Patients With High-Risk Non-Muscle Invasive Bladder Cancer After TURBT and BCG

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Heat Biologics
Sponsor:
Information provided by (Responsible Party):
Heat Biologics
ClinicalTrials.gov Identifier:
NCT02010203
First received: December 5, 2013
Last updated: July 8, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)